Position in IMVT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,332,325
+$73,582 QoQ
Shares Held
93,894
+5.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,194,153,126 across 259 Biotechnology names. IMVT ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in IMVT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,332,325 | 93,894 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,258,743 | 88,857 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,234,822 | 76,602 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,068,000 | 66,750 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $945,280 | 55,312 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $12,484,870 | 504,032 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $16,941,837 | 594,242 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,071,706 | 570,898 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,002,586 | 526,233 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,732,803 | 492,115 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,177,319 | 239,055 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $428,720 | 22,600 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $248,732 | 16,037 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $299,299 | 16,862 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $89,468 | 16,034 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $63,347 | 16,243 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $103,036 | 18,700 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $153,265 | 17,989 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $181,827 | 20,924 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,111,476 | 862,013 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $13,792,185 | 859,862 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $52,078,623 | 1,127,487 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,608,352 | 244,625 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,648,822 | 149,849 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||